Michael A Linden

Associate Professor, Laboratory Medicine and Pathology

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

18 Similar Profiles

Multiple Myeloma Medicine & Life Sciences

Plasma Cell Neoplasms Medicine & Life Sciences

Bone Marrow Medicine & Life Sciences

Flow Cytometry Medicine & Life Sciences

Cell Transplantation Medicine & Life Sciences

Acute Myeloid Leukemia Medicine & Life Sciences

Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences

Plasma Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

43 Article
14 Letter
4 Chapter
3 Comment/debate
5 More

Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study

Lou, E., Vogel, R. I., Hoostal, S., Wong, P., Grad, A., Monu, M., Łukaszewski, T., Deshpande, J., Dickson, E. L., Klein, M., Linden, M. A., Subramanian, S., Teoh, D. & Geller, M. A., Nov 1 2019, In : Oncologist. 24, 11, p. 1422-e1013

Research output: Contribution to journal › Article

Circulating Neoplastic Cells

Platinum

MicroRNAs

Biomarkers

Prospective Studies

CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up

Gilles, S. R., Yohe, S. L., Linden, M. A., Dolan, M. M., Hirsch, B. A. & Grzywacz, B. J., Sep 9 2019, In : American journal of clinical pathology. 152, 4, p. 471-478 8 p.

Research output: Contribution to journal › Article

T-Cell Prolymphocytic Leukemia

Mitogen Receptors

T-Lymphocyte Subsets

Natural Killer Cells

Flow Cytometry

Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease

Cayci, Z., Ozturk, K., Ustun, C., Omer, A. K., Dincer, E., Sachs, Z., Peterson, B. A. & Linden, M. A., Nov 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 11, p. e597-e601

Research output: Contribution to journal › Article

Fluorodeoxyglucose F18

Sarcoidosis

Lymphoma

2 Citations (Scopus)

Sleeping beauty screen identifies RREB1 and other genetic drivers in human B-cell lymphoma

Rahrmann, E. P., Wolf, N. K., Otto, G. M., Heltemes Harris, L. M., Ramsey, L. B., Shu, J., LaRue, R. S., Linden, M. A., Rathe, S., Starr, T., Farrar, M. A., Moriarity, B. S. & Largaespada, D. A., Feb 1 2019, In : Molecular Cancer Research. 17, 2, p. 567-582 16 p.

Research output: Contribution to journal › Article

Beauty

Lymphoma, Large B-Cell, Diffuse

B-Cell Lymphoma

Carrier Proteins

Follicular Lymphoma

Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients with Ovarian Cancer

Lou, E., Vogel, R. I., Hoostal, S., Klein, M. E., Linden, M. A., Teoh, D. G. & Geller, M. A., Aug 1 2019, In : JAMA Oncology. 5, 8, p. 1222-1224 3 p.

Research output: Contribution to journal › Letter

Platinum

Ovarian Neoplasms

Biomarkers

Drug Therapy

Neoplasms